Merck said the Phase 3 "Hyperion" study, which was evaluating Winrevair versus placebo in recently diagnosed adults with PAH at intermediate or high risk of disease progression, had lost clinical ...

A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the pricing of a public offering of an aggregate of ...

Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final ...

GEN Korean BBQ, a Korean barbecue chain with 40 locations across the U.S., recently opened at 1763 State Route 27 in Festival ...

Between their respective rooms, brothers Jack and Charlie Silver have been crafting and refining songs for years. Jack paces ...

Ann Leggett and Esme Orr had exceptional performances for youngsters representing Kingston’s Midtown Jiu Jitsu at the ...

“The City of Rahway’s Black History Month events reflect a deep commitment to diversity, inclusion, and education,” according ...

For a second consecutive year, Union County Tournament bragging rights came down to Scotch Plains-Fanwood and Rahway. Scotch ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

Latest boys basketball Top 10 rankings, news and notes among Skyland Conference and Union County area teams, through Jan. 26 ...

Merck & Co. and Eisai reported mixed results from a late-stage study of the cancer drugs Keytruda and Lenvima in patients with certain types of gastroesophageal cancer.